Skip to main content

Lakewood-Amedex Biotherapeutics Inc.

LABT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002079272

No open-market purchases or sales by Lakewood-Amedex Biotherapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $306.5K in total; no superinvestor holds it.

Superinvestors holding LABT, Q2 2026

See all superinvestors

No superinvestor reported holding LABT in Q2 2026.